Violet Shackleford
Pain Medicine · Morgantown, WVNPI 1821593724
Payments from drug & device makers
What this record shows
This record is dominated by grants: $12,500 of the $16,608 with a category attached, or 75.3%. 10 manufacturers reported payments, led by Medtronic at 56.7% of the total. Reporting peaked in 2022 at $14,531 and has fallen 95.8% since, to $605 in 2025.
Across 58 payments — averaging $286.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Boston Scientific$6K
- Nevro Corp.$438
- Curonix LLC$127
- Valinor Pharma, LLC$78
- Pacira Pharmaceuticals Incorporated$74
- plus $79 from 4 others
What the payments were for
- Grants$12,50075%
- Travel & lodging$1,97812%
- Food & beverage$2,13013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 23 | $9,421 |
| Boston Scientific | 16 | $6,392 |
| Nevro Corp. | 8 | $438 |
| Curonix LLC | 1 | $127 |
| Valinor Pharma, LLC | 4 | $78 |
| Pacira Pharmaceuticals Incorporated | 2 | $74 |
| Tonix Medicines, Inc. | 1 | $26 |
| Vertex | 1 | $19 |
| AbbVie | 1 | $18 |
| Biotronik NRO, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$7,500
- VERCISE$5,000
- INTELLIS ADAPTIVESTIM$1,382
- Senza$232
- Intracept$144
- VECTRIS SURESCAN$136
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$127
How this compares
$16,608 in reported general payments places this provider in the 85th percentile of 35 pain medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 115 | $3,270 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 143 | $2,746 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $675 |
| Oxycodone Hcl | 40 | $605 |
| Pregabalin | 22 | $372 |
| Gabapentin | 33 | $300 |
| Tramadol Hcl | 12 | $80 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Morgantown
- David SaldivarMorgantown$28K
- Richard VaglientiMorgantown$13K
- Brian SlaterMorgantown$6K
- Benjamin BirneyMorgantown$3K
- Trey VanekMorgantown$2K
- Richard BowmanMorgantown$2K
- Nicole HollisMorgantown$1K
- Onyechi MegafuHuntington$37K
- Lucas BraceroCharleston$24K
- Muhammad MaazHuntington$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.